(Total Views: 517)
Posted On: 03/06/2021 12:41:34 AM
Post# of 153886
"I wonder how the progression from severe to critical compares between treatment arm and placebo."
Isn't that what SE #3 is supposed to tell us? So a severe progressing to critical would be category 3 going to category 2. CYDY should have that data and I'm surprised leronlimab doesn't show some significance in that SE.
3. Change in clinical status of subject at Day 28 (on a 7 point ordinal scale) [ Time Frame: Day 28 ]
A 7-category ordinal scale of patient health status ranges from: 1) Death; 2) Hospitalized, on invasive mechanical ventilation or extracorporeal membrane oxygenation (ECMO); 3) Hospitalized, on non-invasive ventilation or high flow oxygen devices; 4) Hospitalized, requiring supplemental oxygen; 5) Hospitalized, not requiring supplemental oxygen; 6) Not hospitalized, limitation on activities; 7) Not hospitalized, no limitations on activities.
Read More: https://investorshangout.com/post/view?id=607...z6oJ7grWPq
Isn't that what SE #3 is supposed to tell us? So a severe progressing to critical would be category 3 going to category 2. CYDY should have that data and I'm surprised leronlimab doesn't show some significance in that SE.
3. Change in clinical status of subject at Day 28 (on a 7 point ordinal scale) [ Time Frame: Day 28 ]
A 7-category ordinal scale of patient health status ranges from: 1) Death; 2) Hospitalized, on invasive mechanical ventilation or extracorporeal membrane oxygenation (ECMO); 3) Hospitalized, on non-invasive ventilation or high flow oxygen devices; 4) Hospitalized, requiring supplemental oxygen; 5) Hospitalized, not requiring supplemental oxygen; 6) Not hospitalized, limitation on activities; 7) Not hospitalized, no limitations on activities.
Read More: https://investorshangout.com/post/view?id=607...z6oJ7grWPq
(1)
(0)
